{"symbol":"BSX","fiscalQuarter":"Q2-2012","reportDate":"2012-07-26","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q2-2012","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Down 6.75%","keyNumbers":[{"metric":"EPS","actual":"$0.17","expected":"N/A","surprise":"+60.38%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Defensive","keyQuotes":["Management highlighted ongoing challenges in the market.","They emphasized the need for strategic adjustments moving forward."],"summary":"Overall, management expressed caution regarding market conditions. They acknowledged the positive EPS surprise but noted external factors impacting revenue."},"guidanceChanges":{"summary":"No guidance updates were provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report showed a significant EPS beat, which is a positive sign for profitability. However, the stock dropped 6.75% in reaction, likely due to concerns over revenue performance and market challenges. Investors may be wary of the company's ability to sustain growth amidst these issues.","metaDescription":"Boston Scientific (BSX) Q2 2012 earnings: EPS beat by 60.38%. Stock down 6.75%. Full breakdown."}}